Phase I-II study of the continuous infusion of doxorubicin in the treatment of non-small cell lung cancer.
D000328:Adult; D000368:Aged; D004317:Doxorubicin / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D007263:Infusions, Parenteral; D008175:Lung Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced
D004317:Doxorubicin